Biología en la sangre: avances en biomarcadores plasmáticos para el diagnóstico de la enfermedad de Alzheimer
Alfredo Ibarra-Sánchez, Claudia Soto-Félix, Leticia Cano Barraza, Delia Barraza Sámano. Star of Sciences Multidisciplinary Journal, 2025-12-19
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
El desarrollo de biomarcadores plasmáticos ha revolucionado el diagnóstico biológico de la enfermedad de Alzheimer (EA), al permitir una detección más temprana y menos invasiva de los procesos neuropatológicos subyacentes. El presente trabajo describe la relevancia de los principales biomarcadores plasmáticos -Aβ42/40, p-tau, NfL, GFAP y ApoE- dentro del marco A/T/N del NIA-AA, así como su potencial integración en la práctica clínica para la evaluación y el seguimiento de la EA. El cociente Aβ42/40 refleja con alta sensibilidad la carga amiloide cerebral, mientras que las isoformas p-tau181 y p-tau217 indican la propagación de la patología tau. Los biomarcadores NfL y GFAP complementan este perfil al evidenciar daño neuronal y activación glial. La apolipoproteína E (ApoE), además de su función en el metabolismo lipídico cerebral, modula la expresión y dinámica de los demás marcadores, integrando los procesos de acumulación amiloide, fosforilación de tau e inflamación neuroglial. La combinación de biomarcadores plasmáticos bajo el esquema A/T/N representa una herramienta diagnóstica de gran valor, que favorece un enfoque de medicina personalizada en la EA. Su implementación progresiva en entornos clínicos permitirá mejorar la detección precoz, la estratificación del riesgo y la monitorización terapéutica, consolidando la transición hacia un modelo diagnóstico basado en la biología de la enfermedad.
What this study adds
Evidence grade: Low
This review describes plasma biomarkers such as Aβ42/40, p-tau181, p-tau217, NfL, GFAP, and ApoE within the A/T/N framework for diagnosing and monitoring Alzheimer's disease. It discusses their potential for earlier, less invasive diagnosis and personalized medicine, but does not report a treatment or cure.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Ibarra-Sánchez, A., Soto-Félix, C., Barraza, L. C., & Sámano, D. B. (2025). Biología en la sangre: avances en biomarcadores plasmáticos para el diagnóstico de la enfermedad de Alzheimer. Star of Sciences Multidisciplinary Journal. https://doi.org/10.63969/141q5f06
Vancouver
Ibarra-Sánchez A, Soto-Félix C, Barraza LC, Sámano DB. Biología en la sangre: avances en biomarcadores plasmáticos para el diagnóstico de la enfermedad de Alzheimer. Star of Sciences Multidisciplinary Journal. 2025. doi:10.63969/141q5f06.
BibTeX
@article{ibarrasanchez2025-5f0eecf0,
author = {Ibarra-Sánchez, Alfredo and Soto-Félix, Claudia and Barraza, Leticia Cano and Sámano, Delia Barraza},
title = {{Biología en la sangre: avances en biomarcadores plasmáticos para el diagnóstico de la enfermedad de Alzheimer}},
journal = {Star of Sciences Multidisciplinary Journal},
year = {2025},
doi = {10.63969/141q5f06},
url = {https://doi.org/10.63969/141q5f06}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- El cociente Aβ42/40 refleja con alta sensibilidad la carga amiloide cerebral, mientras que las isoformas p-tau181 y p-tau217 indican la propagación de la patología tau.
- Los biomarcadores NfL y GFAP complementan este perfil al evidenciar daño neuronal y activación glial.
- La apolipoproteína E (ApoE), además de su función en el metabolismo lipídico cerebral, modula la expresión y dinámica de los demás marcadores, integrando los procesos de acumulación amiloide, fosforilación de tau e inflamación neuroglial.
- La combinación de biomarcadores plasmáticos bajo el esquema A/T/N representa una herramienta diagnóstica de gran valor, que favorece un enfoque de medicina personalizada en la EA.
- Su implementación progresiva en entornos clínicos permitirá mejorar la detección precoz, la estratificación del riesgo y la monitorización terapéutica, consolidando la transición hacia un modelo diagnóstico basado en la biología de la enfermedad.
Why it matters
This review describes plasma biomarkers such as Aβ42/40, p-tau181, p-tau217, NfL, GFAP, and ApoE within the A/T/N framework for diagnosing and monitoring Alzheimer's disease. It discusses their potential for earlier, less invasive diagnosis and personalized medicine, but does not report a treatment or cure.
New to this subject? Start with our plain-English guide: Genetics →
Study details
- Evidence strengthLow
How this study scored 27/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on senior author's track record and institution's track record, so those were left out: it earned 25 of the 93 points we could judge it on, which is 27 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Star of Sciences Multidisciplinary Journal) |
| Journal's citation record | 0 / 4 | Star of Sciences Multidisciplinary Journal: journal h-index 3 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | — / 4 | OpenAlex's profile for last-listed author Delia Barraza Sámano holds only 6 work(s), too few to judge a track record — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 0 institution(s) in 0 countries — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 2 / 2 | Free to read |
| Points | 25 / 93 | Scored on 18 of 20 parts. We have no data for the rest, so they are left out: 25 of the 93 points we could judge it on is 27 out of 100. |
| Total | 27 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.63969/141q5f06
- Original source →
- Free full text: Star of Sciences Multidisciplinary Journal →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 15.
Related studies in Genetics from nearby years
Also in Genetics
201 studies in the library are filed under Genetics with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Genetics hub.